Trastuzumab Deruxtecan
(asked on 19th June 2023) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Excellence is taking steps to approve Enhertu for use in the treatment of cancers other than breast cancer.
This question was answered on 26th June 2023
The National Institute for Health and Care Excellence (NICE) is currently in the early stages of developing technology appraisal guidance on treatments for non-small-cell lung cancer, including Enhertu (trastuzumab deruxtecan) and held a scoping workshop focusing on this topic on 24 April 2023.